These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Are des-Phe-insulin-containing insulin combinations preferable to regular trade preparations?]. Sachse G; Federlin K Med Klin; 1981 May; 76(11):319-23. PubMed ID: 7017364 [TBL] [Abstract][Full Text] [Related]
4. [Experience in the treatment of diabetes mellitus with delayed-action insulin preparations]. PiasetskiÄ NR; Tirkina TN; Danilova NS Klin Med (Mosk); 1967 May; 45(5):22-8. PubMed ID: 5607519 [No Abstract] [Full Text] [Related]
5. [Experience with DB retard in therapy of diabetes]. Grujić M; Perinović M Med Welt; 1975 Mar; 26(12):571-3. PubMed ID: 1134297 [No Abstract] [Full Text] [Related]
6. The optimal use of modern insulins. Campbell I Practitioner; 1994 Jan; 238(1534):46-52. PubMed ID: 8108334 [No Abstract] [Full Text] [Related]
7. Insulin lispro, a new insulin analog. Kucera ML; Graham JP Pharmacotherapy; 1998; 18(3):526-38. PubMed ID: 9620104 [TBL] [Abstract][Full Text] [Related]
8. [Delayed action insulins. What is the value of insulin glargine in general practice?]. MMW Fortschr Med; 2001 Apr; 143(16):54-6. PubMed ID: 11367996 [No Abstract] [Full Text] [Related]
9. [New aspects of insulin therapy]. Andreev D Vutr Boles; 1985; 24(6):49-54. PubMed ID: 3913147 [No Abstract] [Full Text] [Related]
10. [Insulin therapy]. Petrides P Munch Med Wochenschr; 1970 Jul; 112(27):1273-7. PubMed ID: 4246479 [No Abstract] [Full Text] [Related]
11. [Comparative efficacy of long-acting insulin preparations in diabetes mellitus]. Skrobonskaia NA; Lapko LI Vrach Delo; 1969 Oct; 10():29-32. PubMed ID: 5366808 [No Abstract] [Full Text] [Related]
12. [Highly purified insulins in the modern treatment of diabetes]. Woenckhaus JW Med Klin; 1975 Sep; 70(36):1401-7. PubMed ID: 1101007 [No Abstract] [Full Text] [Related]
13. Comparison of injection techniques for soluble and protamine zinc insulins in diabetes mellitus. Harrower AD; Duncan LJ; Clarke BF Practitioner; 1975 Feb; 214(1280):228-31. PubMed ID: 1144249 [TBL] [Abstract][Full Text] [Related]
14. [Action of instantaneous-delayed action phenformin, alone or in combined therapy, in 50 hospitalized diabetics]. Vague J; Vague P; Jaquet P; Gerolami G Mars Med; 1966; 103(4):331-3. PubMed ID: 5997802 [No Abstract] [Full Text] [Related]
15. [Human globin insulin in treatment of diabetes mellitus]. Paron R; Da Broi GL Friuli Med; 1965; 20(1):119-34. PubMed ID: 5318586 [No Abstract] [Full Text] [Related]
16. [Depot insulin with tumor risk. Changing now or staying cool? (interview by Sarah Pampel)]. Spranger J MMW Fortschr Med; 2009 Jul; 151(30-33):22. PubMed ID: 19722454 [No Abstract] [Full Text] [Related]
17. The nature and use of purified insulins. Martin FI Aust Fam Physician; 1976 May; 5(4):514-25. PubMed ID: 952634 [TBL] [Abstract][Full Text] [Related]
18. [Experiences with a depot-body-free delayed-action insulin]. Schliack V; Lotz U Munch Med Wochenschr; 1967 Jun; 109(24):1328-33. PubMed ID: 5631747 [No Abstract] [Full Text] [Related]
19. [Diabetes mellitus. 13. Insulin therapy of diabetes mellitus]. Michaelis D Z Arztl Fortbild (Jena); 1971 Oct; 65(20):1006-13. PubMed ID: 5170112 [No Abstract] [Full Text] [Related]